Bioloxía do Linfocito
BioLinfo
Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (73)
2024
-
Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients
Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 23-32
2023
-
A Study of the Prevalence of Asthma in the General Population in Spain
Open Respiratory Archives, Vol. 5, Núm. 2
-
Alpha-1 antitrypsin deficiency and Pi*S and Pi*Z SERPINA1 variants are associated with asthma exacerbations
Pulmonology
-
Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral Glucocorticoids
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Disposition of Work-Related Asthma in a Spanish Asthma Cohort: Comparison of Asthma Severity Between Employed and Retired Workers
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 11, pp. 3407-3413.e1
-
Does asthma-bronchiectasis overlap syndrome (ABOS) really exist?
Journal of Asthma, Vol. 60, Núm. 11, pp. 1935-1941
-
Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 4, pp. 281-288
-
Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis
Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231
-
Impact of Air Pollution on Asthma: A Scoping Review
Open Respiratory Archives, Vol. 5, Núm. 2
-
Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti–IL-5 Biologics: A Real-Life Study
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 1, pp. 37-44
-
Lung Function Abnormalities and Their Correlation With Clinical Characteristics and Inflammatory Markers in Adult Asthma
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 4, pp. 294-296
-
Omalizumab in Severe Asthma: Effect on Oral Corticosteroid Exposure and Remodeling. A Randomized Open-Label Parallel Study
Drugs, Vol. 83, Núm. 12, pp. 1111-1123
-
Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study
Journal of Medical Virology, Vol. 95, Núm. 7
-
Real-Life Effectiveness of Benralizumab, Mepolizumab and Omalizumab in Severe Allergic Asthma Associated with Nasal Polyps
Clinical Reviews in Allergy and Immunology, Vol. 64, Núm. 2, pp. 179-192
-
Reply to “Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies”
Journal of Investigational Allergology and Clinical Immunology
-
Role of Different Health Care Professionals in the Management of Asthma Patients: The GEMA-FORUM IV Task Force
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 3, pp. 214-217
-
Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 1, pp. 141-155
-
Severe asthma patients’ and physicians’ perspectives of disease burden: do they match?
ERJ Open Research
-
The New ERS/ATS 2022 Bronchodilator Response Recommendation: Comparison With the Previous Version in an Asthma Cohort
Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 608-611
-
Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain
Open Respiratory Archives, Vol. 5, Núm. 3